Read More

They receive high-dose chemotherapy that kills any remaining immune cells. The stem cells are then transfused back into their body to re-grow their immune system.

Results published in the journal JAMA Neurology suggested some patients suffering from MS saw an improvement in their symptoms.

NHS England said the AHSCT treatment is commissioned at specialised centres in the UK but is currently only offered to some people with MS.

Susan Timlin with Dr Guarav Kharya and his team at a hospital in New Delhi (Image: Therese Timlin)

A spokesman said: “There is not yet an adequate controlled trial of its efficacy relative to other potent therapies.

“We recommend that it is made available equitably to all people with MS, but it should only be considered for people with relapsing disease who have failed high-activity licensed disease-modifying therapies, and are prepared to accept the significant risks of the procedure and are eligible under European Group for Blood and Marrow Transplantation guidelines.”

Susan’s family has launched a fundraising page to help pay for the trip.